ZyVersa Therapeutics Inc. Strategic Asset Allocation Index
ZyVersa Therapeutics Inc. strategic asset allocation index. ZyVersa Therapeutics Inc. (ZVSA) has a Strategic Asset Allocation Index of 0.1% as of December 2022. Strategic assets (PP&E of $115.70K plus long-term investments of $-) total $115.70K, measured against net assets of $99.99 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ZVSA net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of ZyVersa Therapeutics Inc. (2022–2022)
Strategic asset allocation index of ZyVersa Therapeutics Inc. from 2022 to 2022. This chart shows how ZyVersa Therapeutics Inc.'s Strategic Asset Allocation Index has evolved across 1 annual periods from 2022 to 2022. As of December 2022, the index stands at 0.1%, representing strategic assets of $115.70K against net assets of $99.99 Million USD. Check ZVSA intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
ZyVersa Therapeutics Inc. Strategic Asset Allocation Index by Year (2022–2022)
ZyVersa Therapeutics Inc. strategic asset allocation index by year from 2022 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for ZyVersa Therapeutics Inc. from 2022 to 2022, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ZyVersa Therapeutics Inc. (ZVSA) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | $115.70K | $115.70K | $- | $99.99 Million | — |